Keio University

Press Releases & Media

51-60 items (total 83)
Published on February 02, 2023

An Interview with Professor Kim Yoon-gi Published in *Business Insider Japan*.

Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences

Published on December 23, 2022

Newly Developed Multilayered Human Skeletal Muscle Tissue Model and Contractile Force Measurement System Useful for Myopathy Research

Office of Communications and Public Relations

Published on December 19, 2022

Development of a New Structural Analysis Method to Identify the Double Bond Positions in Lipids: Contributing to the Elucidation of Lipid Metabolism Mechanisms with Mass Spectrometry and Data Science

Office of Communications and Public Relations

Published on December 07, 2022

Demonstration of High-Accuracy Differentiation of 13 Cancer Types Using Blood microRNAs—Release of the World's Largest Human Serum microRNA Database—

Office of Communications and Public Relations

Published on November 11, 2022

A feature on the Keio University Faculty of Pharmacy has been published in *The Encyclopedia of Medical School Admissions, 2023 Definitive Edition* (President Inc.).

Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences

Published on November 01, 2022

An interview with Professor Juichi Otani was published in *Turn Up*, no. 59 (Pharmasy Co., Ltd.).

Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences

Published on October 25, 2022

Measurement of Red Blood Cell Parameters and BRCA1/2 Gene Mutations Before Treatment Can Predict Severe Anemia Caused by Olaparib, a Standard Cancer Therapy - A Step Toward Early Detection and Treatment Management of "High-Risk Patients" -

Office of Communications and Public Relations

Published on October 19, 2022

An interview with Associate Professor Juntaro Matsuzaki, “Developing Strategies to Control COVID-19 Using Extracellular Vesicles,” is now available on the website of the Chemo-Sero-

Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences

Published on September 14, 2022

Discovery that Differences in Dietary Protein Sources Alter the Pathology of Infectious Diarrhea via Gut Microbiota—Hopes for Developing Prevention Methods for Clostridioides difficile Infection by Targeting Diet and Gut Microbiota—

Office of Communications and Public Relations

Published on August 19, 2022

Discovery that D-tryptophan suppresses the growth of pathogenic bacteria in the gut and prevents enteritis—with expectations for the development of new functional materials to improve the gut environment

Office of Communications and Public Relations